Co-reporter:Xianfeng Zeng, Peiyao Wu, Chengbo Yao, Jiaqi Liang, Shuting Zhang, and Hang Yin
Biochemistry April 18, 2017 Volume 56(Issue 15) pp:2076-2076
Publication Date(Web):March 29, 2017
DOI:10.1021/acs.biochem.6b00909
Membrane proteins play vital roles in cell signaling, molecular transportation, and cell adhesion. The interactions of transmembrane domains are much less well understood than those of their water-soluble counterparts, and they have been deemed “undruggable” despite their important biological functions such as protein anchoring, signal transduction, and ligand recognition. Nevertheless, continual developments in this area have revealed useful probes for investigating and regulating these membrane proteins. This review summarizes and evaluates the strategies available for discovering small molecules and peptides that recognize the protein transmembrane domains of membrane proteins, with a particular focus on rational design and library screening.
Co-reporter:Lei Yan, Jiaqi Liang, and Hang Yin
ACS Chemical Neuroscience 2016 Volume 7(Issue 4) pp:418
Publication Date(Web):December 10, 2015
DOI:10.1021/acschemneuro.5b00310
Neuroinflammation has been conceived as an important cause for or contributor to neurological diseases. With major strides in new technology, scientists can use chemical biology tools developed in non-neuronal systems to research neuroinflammation. Extracellular vesicles (EVs) play a vital role in mediating neuroinflammation via carrying pathogenic misfolded proteins as well as nucleic acids, suggesting important biological functions. Nonetheless, it is a daunting goal to study these ultramicroscopic EVs in part due to the technical hurdle of specific labeling and preparation. Therefore, development of new detection methods of EVs will promote further understanding of EVs in the nervous system, thereby expediting the diagnosis and therapy development for neurological disorders. Recent progress toward a new class of chemical biology probes simultaneously targeting the highly curved surface and the particular lipid compositions of EVs may offer an alternative strategy for their detection, isolation, and purification, which not only will facilitate research on their mechanism in neuroinflammation and neurological diseases, but also may lay the groundwork for the next generation of diagnostics and prognostics.Keywords: detection technology; drug discovery; extracellular vesicles; lipidomics; membrane curvature; Neuroinflammation
Co-reporter:Lei Yan;Jiaqi Liang;Chengbo Yao;Peiyao Wu;Xianfeng Zeng;Dr. Kui Cheng ;Dr. Hang Yin
ChemMedChem 2016 Volume 11( Issue 8) pp:
Publication Date(Web):
DOI:10.1002/cmdc.201600184
Co-reporter:Lei Yan;Jiaqi Liang;Chengbo Yao;Peiyao Wu;Xianfeng Zeng;Dr. Kui Cheng ;Dr. Hang Yin
ChemMedChem 2016 Volume 11( Issue 8) pp:822-826
Publication Date(Web):
DOI:10.1002/cmdc.201500471
Abstract
Protein–protein interactions have been regarded as “undruggable” despite their importance in many biological processes. The complex formed between host toll-like receptor 5 (TLR5) and flagellin, a globular protein that is the main component of a bacterial flagellum, plays a vital role in a number of pathogen defenses, immunological diseases and cancers. Through high-throughput screening, we identified two hits with a common pharmacophore, which were used to successfully develop a series of small-molecule probes as novel inhibitors of flagellin binding to TLR5. In a multitude of assays, 4-((4-benzyl-5-(pyridin4yl)-4H-1,2,4-triazol-3-yl)thio)pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidine (TH1020) was identified as a potent antagonist of TLR5 signaling with promising activity (IC50=0.85±0.12 μm) and specificity. Furthermore, TH1020 was shown to repress the expression of downstream TNF-α signaling pathways mediated by the TLR5/flagellin complex formation. Based on molecular docking simulation, TH1020 is suggested to compete with flagellin and disrupt its association with TLR5. TH1020 provides a much-needed molecular probe for studying this important protein–protein interaction and a lead compound for identifying novel therapeutics targeting TLR5.
Co-reporter:Meng Gao, Nir London, Kui Cheng, Ryo Tamura, Jialin Jin, Ora Schueler-Furman, Hang Yin
Tetrahedron 2014 70(42) pp: 7664-7668
Publication Date(Web):
DOI:10.1016/j.tet.2014.07.026